Related Experiment Videos
Structural studies of the acquired immunodeficiency syndrome virus reverse transcriptase
B A Larder1, D J Purifoy, K L Powell
1Wellcome Research Laboratories, Langley Court, Beckenham, Kent, United Kingdom.
The American Journal of Medicine
|August 29, 1988
Summary
The human immunodeficiency virus (HIV) reverse transcriptase (RT) is a key drug target. Researchers produced large amounts of HIV RT in E. coli for structural and functional studies to aid in designing new inhibitors.
Area of Science:
- Biochemistry
- Structural Biology
- Virology
Background:
- Zidovudine's success highlights HIV reverse transcriptase (RT) as a critical target for AIDS drug development.
- Understanding HIV RT's structure is essential for rational drug design.
Purpose of the Study:
- To establish a bacterial expression system for producing large quantities of HIV RT.
- To facilitate structural and functional studies of HIV RT.
- To identify key amino acid residues involved in enzyme activity and substrate binding.
Main Methods:
- Development of an expression system in Escherichia coli for recombinant HIV RT production.
- Purification and crystallization of recombinant HIV RT.
- Site-directed mutagenesis for structural/functional analysis of HIV RT.
Main Results:
- Successful production and purification of substantial amounts of active HIV RT.
- Crystallization of HIV RT for ongoing three-dimensional structure elucidation.
- Identification of essential amino acid residues critical for enzyme activity and potential substrate binding.
Conclusions:
- The bacterial expression system provides a valuable tool for studying HIV RT structure and function.
- Structural and functional insights gained will support the rational design of novel HIV RT inhibitors.
- This research contributes to the development of more effective treatments for acquired immunodeficiency syndrome (AIDS).